Skip to content

MRXCapital markets (commodity clearing & brokerage)

Marex Group

No moat (AI estimate)High uncertainty (AI estimate)

Updated

Price
$71.92
Fair value
fair value $70.50 (AI estimate)
Discount
-2.0% above fair value
LSEG rating
LSEG 2.00 — lower is better (1–5)
Next earnings
Earnings Nov 5 · · estimated

Loading your notes…

In short

Thesis
The market expects Marex to keep most of its record 2026 profit, so the price holds only if profit grows in quarters of normal volatility and the control weaknesses are fixed.
Gap
Can close. The Q3 2026 results and the next quarters of normal volatility show within about a year which profit level is the true base.
Next test
(estimate): Q3 2026 results with normal volatility

About

Marex is a financial services firm for commodity and financial markets. It clears trades on many exchanges, executes orders for clients, makes markets, and sells hedging and structured products. Its clients include commodity producers, consumers and traders, banks, hedge funds and asset managers. Marex earns fees and commissions, trading income, and interest on the cash that clients keep with it as margin.

It has four segments: Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions. The company started in London and listed on Nasdaq in April 2024. In July 2026 its parent company moved to Bermuda.

Thesis

The market prices Marex above the AI estimate, because it expects Marex to keep most of its record profit of 2026. In the first half of 2026, very high commodity volatility made market making and trading unusually profitable. But Q2 2026 was also a record quarter, and clearing balances, prime services and acquisitions keep adding fee and interest income. The AI estimate gives equal weight to two cases: profit goes back to the 2025 level plus growth, or the first-half 2026 level is the new base.

Trust issues hold the price back. A short seller accused Marex of accounting manipulation in August 2025, and the 2025 annual report showed two material weaknesses in internal control. Falling interest rates also reduce the interest Marex earns on client cash. For the price to hold, adjusted profit must keep growing in quarters with normal volatility, and there must be no large new client default.

The 2026 annual report must also show that the control weaknesses are fixed. If profit falls back toward the 2025 level when volatility eases, the price can fall to the AI estimate or below. The evidence arrives with the Q3 2026 results, expected in November 2026, the closing of the Bright Point and Brainchild acquisitions in late 2026 or early 2027, and the 2026 annual report in March 2027. Over the next three to five quarters, these reports show which of the two cases is correct.

Valuation

The fair value, the moat and the uncertainty on this page for Marex are an AI estimate from October 8, 2026. They are not an analyst's values.

Checkpoints

  1. Nov 5, 2026 · est.Pending
    Q3 2026 results with normal volatilityAdjusted profit before tax up 10% or more from Q3 2025 with no large client loss passes; a fall in profit as volatility eases fails.
  2. Q1 2027 · est.Pending
    Bright Point and Brainchild acquisitions closeBoth deals close by early 2027 and add client balances without write-downs passes; a delay, a block or a write-down fails.
  3. Mar 2027 · est.Pending
    2026 annual report and internal control opinionManagement and the auditor report that both material weaknesses are fixed passes; any remaining weakness or a restatement fails.

Every passed and failed checkpoint across all picks

Balance sheet

Marex is a broker and clearing firm, so its balance sheet is large compared with its equity. At June 30, 2026, total assets were $42.1 billion and total equity was $1.87 billion.

Risks

  • Profit may fall when commodity volatility returns to normal. In the first half of 2026, trading income was double the level of a year earlier.
  • A client can fail to pay margin in a fast market. Marex must then cover the loss, as it did with a $34 million loss in January 2026.
  • Marex has two material weaknesses in internal control, and a short seller has accused it of accounting manipulation. A failure to fix the controls, or any restatement, would damage trust.
  • Lower interest rates reduce the interest Marex earns on client cash. A 1 percentage point fall in rates cuts this income by about $34 million a year.
  • Marex buys several companies each year. A bad purchase or a weak integration could cause losses or write-downs.
  • Marex funds itself partly with short-dated structured notes and client cash. In stress, this money can leave quickly.
  • After the move to Bermuda, the group capital measure is set by management, not by the UK regulator. A regulator could later require more capital.

Recent events

  • October 7, 2026Marex said that Robert Pickering left the Group Board at the end of his three-year term as Chair. He was Chair from October 2023. John Pietrowicz became Chair. He joined the board in April 2024 and was CFO of CME Group from 2014 to 2023.
  • September 9, 2026Marex paid a quarterly dividend of $0.16 per share for Q2 2026, up from $0.15 for Q4 2025.
  • August 21, 2026Marex agreed to pay $950,000 to settle a US class action that repeated the claims of the short seller NINGI Research. The plaintiffs asked the court for preliminary approval. The settlement still needs final court approval.
Show 8 older events
  • August 12, 2026Marex reported Q2 2026 results. Revenue was $695.8 million, up 39%. Adjusted profit before tax was $165.9 million, up 56%. On the results call, the CEO said that he is confident that Marex can grow at least in line with the top of its 10% to 20% target range for profit growth. From Q2 2026, adjusted earnings per share deduct the coupon on the new hybrid notes.
  • August 10, 2026Marex agreed to buy Brainchild Capital Investments, a Dutch firm that clears and executes power and gas trades. Completion is expected in late 2026 or early 2027. On the same day, the two largest owners from before the listing filed reports that they held no Marex shares at June 30, 2026.
  • August 3, 2026Marex completed its purchase of Webb Traders, a European equity derivatives market maker, for an initial payment of EUR 69.9 million.
  • July 9, 2026Marex agreed to buy Bright Point International, a Singapore clearing firm with about $800 million of client balances. Completion is expected in late 2026 or early 2027.
  • July 1, 2026Marex moved its parent company from England and Wales to Bermuda. The group is no longer under the UK FCA's group capital rules. Its regulated subsidiaries stay under their own regulators.
  • June 9, 2026Marex issued $500 million of perpetual hybrid notes at 7.70%. By June 11, it bought back $94.7 million of its $100 million of 13.25% AT1 notes at 109% of their face value.
  • May 6, 2026Marex reported Q1 2026 results. Adjusted profit before tax was $152.7 million, up 59%. A natural gas client default in January caused a $33.9 million loss in Clearing.
  • March 25, 2026Marex filed its 2025 annual report. Management and the auditor reported two material weaknesses in internal control, in IT access and in balance sheet reconciliations.

Similar companies

  • UNHUnitedHealth GroupShares: Regulation and courts
    Discount
    20.1%
    LSEG
    1.97
    Gap
    Can close
  • APPAppLovinShares: Regulation and courts
    Discount
    41.1%
    LSEG
    1.94
    Gap
    Can close
  • PCGPG&EShares: Regulation and courts
    Discount
    36.0%
    LSEG
    2.39
    Gap
    Will probably not close
  • BTIBritish American TobaccoShares: Regulation and courts
    Discount
    11.9%
    LSEG
    1.50
    Gap
    Will probably not close
  • RBGLYReckitt BenckiserShares: Regulation and courts
    Discount
    26.3%
    LSEG
    2.33
    Gap
    Can close

Read it all? Star MRX or pass, then go on to the next one.